Insiders AbbVie Inc.

Equities

ABBV

US00287Y1091

Pharmaceuticals

Market Closed - Nyse Other stock markets 16:00:02 2025-01-24 EST			5-day change	1st Jan Change
170.30 ^USD	-0.22%		-0.73%	-4.16%

01-23	AbbVie, Neomorph Form Collaboration to Develop Molecular Glue Degraders	MT
01-23	AbbVie Closes Nimble Therapeutics Purchase	MT

Insiders

Crinetics Pharmaceuticals, Inc. Appoints Isabel Kalofonos as Chief Commercial Officer	12-16	CI
PureTech Health plc Appoints Lauren White as Chief Financial Officer	11-05	CI
Incannex Healthcare Inc. Announces Appointment of Dr. Lou Barbato as Chief Medical Officer	24-10-24	CI
CSL Limited Appoints Elaine Sorg as an Independent Non-Executive Director, Effective 1 September 2024	24-08-12	CI
Fate Therapeutics, Inc. Appoints Neely Mozaffarian to its Board of Directors	24-07-31	CI
Abbvie Announces Appointment of Roopal Thakkar as Executive Vice President, Research & Development and Chief Scientific Officer	24-07-10	CI
Merus Names New Chief Medical Officer	24-07-01	MT
AbbVie: new CEO takes up post	24-07-01	CF
AbbVie Says Robert Michael Assumes CEO Role	24-07-01	MT
AbbVie Announces Board Changes	24-07-01	CI
AbbVie Inc. Announces Board of Directors Changes	24-06-20	CI
Abbvie Inc. Announces Board Changes, Effective July 1, 2024	24-04-26	CI
Abbvie Insider Sold Shares Worth $3,716,757, According to a Recent SEC Filing	24-03-22	MT
Abbvie Insider Sold Shares Worth $10,539,508, According to a Recent SEC Filing	24-03-21	MT
Abbvie Insider Sold Shares Worth $1,754,555, According to a Recent SEC Filing	24-03-01	MT
Abbvie Insider Sold Shares Worth $12,153,957, According to a Recent SEC Filing	24-03-01	MT
Abbvie Insider Sold Shares Worth $908,688, According to a Recent SEC Filing	24-03-01	MT
Abbvie Insider Sold Shares Worth $2,509,002, According to a Recent SEC Filing	24-03-01	MT
Abbvie Insider Sold Shares Worth $9,184,048, According to a Recent SEC Filing	24-02-23	MT
AbbVie CEO to Retire; COO Robert Michael Named Successor	24-02-20	MT
AbbVie Names Robert Michael CEO, Richard Gonzalez Executive Chair	24-02-20	MT
AbbVie Names Robert Michael to Succeed Richard Gonzalez as CEO	24-02-20	DJ
AbbVie Names President Robert Michael as CEO	24-02-20	MT
Abbvie, Inc. Appoints Robert A. Michael as Member of the Board of Directors and Richard A. Gonzalez as Executive Chairman of the Board of Directors	24-02-20	CI
AbbVie Inc. Announces Chief Executive Officer Changes	24-02-20	CI

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders AbbVie Inc.

Equities

ABBV

US00287Y1091

Pharmaceuticals

Insiders

Filters